PharmaShots | Incisive News in 3 Shots

Subscribe Now

Cybin

Cybin Commences the P-II Clinical Evaluation of CYB004 for Treating Generalized Anxiety Disorder

Cybin Commences the P-II Clinical Evaluation of CYB004 for Treating Generalized Anxiety Disorder

March 18, 2024

Cybin to Acquire Small Pharma and Create an International Clinical-Stage Leader in Novel Psychedelic Therapeutics

Cybin to Acquire Small Pharma and Create an International Clinical-Stage Leader in Novel Psychedelic Therapeutics

August 29, 2023

Cybin Initiates Dosing of CYB003 in Final Cohort of the P-II Trial for Major Depressive Disorder

Cybin Initiates Dosing of CYB003 in Final Cohort of the P-II Trial for Major Depressive Disorder

August 2, 2023

Cybin Reports Dosing of First Two Patients in P-I/IIa Clinical Trial of CYB003 for the Treatment of Major Depressive Disorder

Cybin Reports Dosing of First Two Patients in P-I/IIa Clinical Trial of CYB003 for the Treatment of Major Depressive Disorder

August 31, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us